As of 2024-12-14, the Fair Value of Knight Therapeutics Inc (GUD.TO) is -1.52 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.20 CAD, the upside of Knight Therapeutics Inc is -129.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 14.50 | 42.10 | 15.68 | -29.89 | -16.83 | 5.11 |
| YoY growth | -39.83% | 190.34% | -62.77% | -290.70% | 43.68% | -31.85% |
| Market Cap (mil) | 524.16 |
| P/E | |
| Forward P/E |
| EPS | -0.30 |
| Avg earnings growth rate | -31.85% |
| TTM earnings | -30.73 |